Precision fermentation

01Overview and value chain#

Markers EC: EU Novel Food Regulation | OECD: Food Systems | Regulator: FDA (USA), EFSA (EU), NMPA (China)

Precision fermentation uses genetically engineered microbes — yeast, filamentous fungi and bacteria — as cell factories for specific high-value molecules: dairy and egg proteins, HMOs, industrial enzymes, vitamins and flavors. Optimized strains reach 30–50 g/L of target product at >90% purity, and the cost of alternative proteins is falling on a trajectory from $10–20/kg (2020) toward a target of $3–6/kg. Versus animal agriculture the technology cuts land use by 95%, water use by 90% and greenhouse-gas emissions by 80%. The synergy is the pairing of a designed strain with a tuned upstream-downstream process and real-time PAT analytics.

Key directions of precision fermentation:

1. Animal-free dairy proteins (Animal-Free Dairy Proteins): β-lactoglobulin and casein secreted by engineered yeast and fungi.
2. Egg proteins (Egg Proteins): ovalbumin for baking and foaming (FDA GRAS since 2023).
3. HMOs and bioactives (HMOs & Bioactives): 2’-fucosyllactose and lacto-N-neotetraose for infant nutrition.
4. Industrial enzymes and flavors (Enzymes & Flavours): proteases, lipases, vanillin and terpenes via precision-fermentation strains.

Sectoral value chain#

[strain design] ──> [fermentation] ──> [harvest] ──> [purification]
                          │
                  (cell factory)
                          │
                          ▼
[ingredient] <─── [drying/formulation] <─────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Strain engineering (Strain Engineering): CRISPR rewiring of hosts (S. cerevisiae, Pichia, Trichoderma, Corynebacterium) for 5–10× titer gains.
• Microbial platforms (Microbial Platforms): yeast (proteins, flavors), fungi (enzymes), bacteria (amino acids, vitamins).
• Process analytical technology (PAT): inline spectroscopy (Raman, NIR) driving feed and induction.

02US#

The US is the technology leader: >200 companies, a 4.5B market (2024),8+B of VC (2019–2024), and the FDA GRAS route.

FDA GRAS pathway, alt-protein venture cluster, USDA/NSF scale-up funding#

• FDA GRAS: voluntary GRAS notification for precision-fermentation ingredients (15+ clearances).
• Perfect Day: the world’s first commercial animal-free whey (Trichoderma), partnering with General Mills.
• New Culture: animal-free casein mozzarella built on microbial casein, targeting pizzeria melt performance.
• Checkerspot: diversifies precision fermentation beyond food into microalgal-derived specialty oils and biopolymers (Algenesis thermoplastic polyurethanes).
• USDA ARS + NSF Future Manufacturing: $150M/year toward biomanufacturing scale-up.

03CN#

China bets on scale and food security: $6B committed in the 14th Five-Year Plan for biomanufacturing (2021–2025).

14th Five-Year Plan, amino-acid & enzyme scale, alternative-protein pilots#

• Angel Yeast (Yichang): $500M expansion,50,000 t of alternative proteins.
• Phycon Biotech (Shanghai): 5,000 t/year dairy-protein pilot, $4/kg target price.
• Meihua/BBCA: global leaders in amino acids and organic acids via fermentation.

04EU#

The EU is strong in designer food proteins and enzymes, but constrained by an acute shortage of pilot bioreactor capacity and the Novel Food regime.

Novel Food & EFSA, CMO capacity bottleneck, designer dairy proteins#

• EU Novel Food (EC 2015/2283): EFSA approval plus mandatory GMM-DNA clearance.
• Formo (Berlin): synthetic casein/whey from Trichoderma, cheeses in REWE, -96% carbon footprint.
• Remilk (Israel/Denmark): microbial dairy proteins produced at its Kalundborg, Denmark facility, with FDA GRAS clearance.
• Better Dairy (UK): London-based precision-fermentation cheese maker producing animal-free casein.
• CMO platforms: BBEPP (Belgium) and TWB (France) rent bioreactors to startups.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack binds a designed strain to an instrumented process with PAT control.

1. Yeast platform (Yeast Platform):
   • S. cerevisiae and Pichia pastoris for proteins and flavors, at 30–50 g/L.
   • case: Perfect Day — the first commercial precision-fermentation whey.
2. Filamentous fungi (Filamentous Fungi):
   • Trichoderma/Aspergillus for enzyme and protein secretion.
   • case: Formo — Trichoderma casein for meltable cheeses.
3. Bacterial platforms (Bacterial Platforms):
   • Corynebacterium/E. coli for amino acids and vitamins with fast growth.

07Value chains and production pipelines#

Industrial pipeline of a precision-fermentation ingredient (ISO 22000 / GMP)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Strain build           │ ───> │ 2. Seed train             │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Purification (GMM too) │ <─── │ 3. Fermentation           │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Drying & formulation   │ ───> │ 6. B2B application        │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Strain build

A host is reprogrammed (CRISPR, synthetic biology) to secrete the target molecule at 30–50 g/L titer.

Stage 2: Seed train

A cell bank is expanded through staged seed bioreactors to production volume.

Stage 3: Fermentation

Fed-batch or continuous runs convert sugar feedstock into product broth under PAT control.

Stage 4: Purification

Chromatography and TFF isolate the molecule to >90% purity; in the EU, GMM-DNA clearance is mandatory.

Stage 5: Drying & formulation

Spray-drying yields a standardized ingredient powder.

Stage 6: B2B application

The ingredient enters food, beverage, nutrition and cosmetic products.